These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 12757707)

  • 21. Co-chaperone CHIP promotes aggregation of ataxin-1.
    Choi JY; Ryu JH; Kim HS; Park SG; Bae KH; Kang S; Myung PK; Cho S; Park BC; Lee DH
    Mol Cell Neurosci; 2007 Jan; 34(1):69-79. PubMed ID: 17127076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SCA1-phosphorylation, a regulator of Ataxin-1 function and pathogenesis.
    Orr HT
    Prog Neurobiol; 2012 Dec; 99(3):179-85. PubMed ID: 22531670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amino acid sequences flanking polyglutamine stretches influence their potential for aggregate formation.
    Nozaki K; Onodera O; Takano H; Tsuji S
    Neuroreport; 2001 Oct; 12(15):3357-64. PubMed ID: 11711886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beyond the glutamine expansion: influence of posttranslational modifications of ataxin-1 in the pathogenesis of spinocerebellar ataxia type 1.
    Ju H; Kokubu H; Lim J
    Mol Neurobiol; 2014 Dec; 50(3):866-874. PubMed ID: 24752589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of genetic modifiers in Drosophila points to common and distinct mechanisms of pathogenesis among polyglutamine diseases.
    Branco J; Al-Ramahi I; Ukani L; Pérez AM; Fernandez-Funez P; Rincón-Limas D; Botas J
    Hum Mol Genet; 2008 Feb; 17(3):376-90. PubMed ID: 17984172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias--triple-labeling immunofluorescence study.
    Uchihara T; Fujigasaki H; Koyano S; Nakamura A; Yagishita S; Iwabuchi K
    Acta Neuropathol; 2001 Aug; 102(2):149-52. PubMed ID: 11563629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antisense RNA sequences modulating the ataxin-1 message: molecular model of gene therapy for spinocerebellar ataxia type 1, a dominant-acting unstable trinucleotide repeat disease.
    Gao Y; Zu T; Low WC; Orr HT; McIvor RS
    Cell Transplant; 2008; 17(7):723-34. PubMed ID: 19044200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice.
    Cummings CJ; Reinstein E; Sun Y; Antalffy B; Jiang Y; Ciechanover A; Orr HT; Beaudet AL; Zoghbi HY
    Neuron; 1999 Dec; 24(4):879-92. PubMed ID: 10624951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RAS-MAPK-MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1.
    Park J; Al-Ramahi I; Tan Q; Mollema N; Diaz-Garcia JR; Gallego-Flores T; Lu HC; Lagalwar S; Duvick L; Kang H; Lee Y; Jafar-Nejad P; Sayegh LS; Richman R; Liu X; Gao Y; Shaw CA; Arthur JSC; Orr HT; Westbrook TF; Botas J; Zoghbi HY
    Nature; 2013 Jun; 498(7454):325-331. PubMed ID: 23719381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell biology of spinocerebellar ataxia.
    Orr HT
    J Cell Biol; 2012 Apr; 197(2):167-77. PubMed ID: 22508507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel function of Ataxin-1 in the modulation of PP2A activity is dysregulated in the spinocerebellar ataxia type 1.
    Sánchez I; Piñol P; Corral-Juan M; Pandolfo M; Matilla-Dueñas A
    Hum Mol Genet; 2013 Sep; 22(17):3425-37. PubMed ID: 23630944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SCA1 molecular genetics: a history of a 13 year collaboration against glutamines.
    Orr HT; Zoghbi HY
    Hum Mol Genet; 2001 Oct; 10(20):2307-11. PubMed ID: 11673415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polyglutamines placed into context.
    La Spada AR; Taylor JP
    Neuron; 2003 Jun; 38(5):681-4. PubMed ID: 12797953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyglutamine neurodegeneration: minding your Ps and Qs.
    Paulson H
    Nat Med; 2003 Jul; 9(7):825-6. PubMed ID: 12835695
    [No Abstract]   [Full Text] [Related]  

  • 35. p80 coilin, a coiled body-specific protein, interacts with ataxin-1, the SCA1 gene product.
    Hong S; Ka S; Kim S; Park Y; Kang S
    Biochim Biophys Acta; 2003 May; 1638(1):35-42. PubMed ID: 12757932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyglutamine disease toxicity is regulated by Nemo-like kinase in spinocerebellar ataxia type 1.
    Ju H; Kokubu H; Todd TW; Kahle JJ; Kim S; Richman R; Chirala K; Orr HT; Zoghbi HY; Lim J
    J Neurosci; 2013 May; 33(22):9328-36. PubMed ID: 23719801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families.
    Brusco A; Gellera C; Cagnoli C; Saluto A; Castucci A; Michielotto C; Fetoni V; Mariotti C; Migone N; Di Donato S; Taroni F
    Arch Neurol; 2004 May; 61(5):727-33. PubMed ID: 15148151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glial S100B protein modulates mutant ataxin-1 aggregation and toxicity: TRTK12 peptide, a potential candidate for SCA1 therapy.
    Vig PJ; Hearst S; Shao Q; Lopez ME; Murphy HA; Safaya E
    Cerebellum; 2011 Jun; 10(2):254-66. PubMed ID: 21384195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic effects of expanded ataxin-1 polyglutamines with interruptions in vitro.
    Calabresi V; Guida S; Servadio A; Jodice C
    Brain Res Bull; 2001 Oct-Nov 1; 56(3-4):337-42. PubMed ID: 11719269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyglutamine expansion accelerates the dynamics of ataxin-1 and does not result in aggregate formation.
    Krol HA; Krawczyk PM; Bosch KS; Aten JA; Hol EM; Reits EA
    PLoS One; 2008 Jan; 3(1):e1503. PubMed ID: 18231590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.